在米特拉门手术后进行永久心脏起器植入. 最先进的范围审查审查
Janina Finke1,2, Michał Pasierski1,2, Emil J Dąbrowski3
1Department of Cardiac Surgery and Transplantology, National Medical Institute of the Ministry of Interior and Administration, Warsaw, Poland.
概括
mitra 门手术后永久心脏起器植入发生在1-10%的病例中,通常是由于心房静脉阻塞. 识别风险因素和优化手术方法可以帮助减少对心脏起器的需求.
科学领域:
- 心血管外科心血管外科
- 电力生理学 电力生理学
- 医疗器械技术 医疗器械技术
背景情况:
- 永久心脏起器植入是 mitra 门手术后的潜在并发症.
- 了解其发病率,征兆和风险因素对于患者管理至关重要.
研究的目的:
- 为了进行对米特拉门手术后永久心脏起器植入的范围审查.
- 调查流行率,征兆,风险因素,时间和结果.
主要方法:
- 在PubMed,Embase和Cochrane数据库中进行全面的文献搜索.
- 包括过去二十年的临床研究和评论.
- 专注于患病率,说明,风险因素,时间,设备选择和长期依赖.
主要成果:
- 心脏起器植入的发病率在1%到10%之间,心房阻塞是主要的征兆.
- 风险因素包括年龄较大,心房动,心房动功能减弱和之前的心脏手术.
- 中心置换,微创手术和左心房切除方法影响心脏起器率;长期依赖程度不同 (20-60%).
结论:
- mitra 门手术后永久心脏起器植入受因素的复杂相互作用的影响.
- 需要进一步的研究来最大限度地减少术后导电异常,并确定有风险的患者进行长期随访.
相关概念视频
Mitral Stenosis III: Medical Management
28
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
28
Mitral Valve Prolapse II: Assessment and Management
45
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
45
Mitral Regurgitation III: Medical Management
34
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
34
Mitral Valve Prolapse I: Introduction
50
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
50
Mitral Valve Prolapse III: Nursing Management
41
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
41
Mitral Regurgitation I: Introduction
64
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
64


